ER-β Alleles | |||
---|---|---|---|
Characteristic | Ca | Gb | |
Breast cancer | |||
Case | (n = 150) | 283(94.3%) | 17(5.7%) |
Control | (n = 147) | 294(100%) | - |
χ2 = 17.122, P = 0.001 | |||
Age at menarche(years) | |||
</= 12 | (n = 60) | 109(90.8%) | 11(9.2%) |
> 12 | (n = 90) | 174(96.7%) | 6(3.3%) |
χ2 = 4.583, P = 0.032 | |||
Age at menopause (years) | |||
=< 50 | (n = 47) | 87(92.6%) | 7(7.4%) |
> 50 | (n = 12) | 24(100%) | - |
χ2 = 1.884, P = 0.17 | |||
ABO blood groups | |||
A | (n = 27) | 51(94.4%) | 3(5.6%) |
B | (n = 14) | 26(92.9%) | 2(7.1%) |
AB | (n = 6) | 12(100%) | - |
O | (n = 103) | 194(94.2%) | 12(5.8%) |
χ2 = 0.058, P = 0.81 | |||
Race | |||
Arab & Armani | (n = 3) | 6(100%) | - |
Fars | (n = 60) | 114(95.0%) | 6(5.0%) |
Lor & Kurdish | (n = 18) | 32(88.9%) | 4(11.1%) |
Turkish | (n = 46) | 88(95.7%) | 4(4.3%) |
Gilaki & Mazani | (n = 23) | 43(93.5%) | 3(6.5%) |
χ2 = 0.05, P = 0.822 | |||
Family history of breast cancer | |||
First-degree family affected | (n = 19) | 24(63.2%) | 14(36.8%) |
Not affected | (n = 131) | 259(98.9%) | 3(1.1%) |
χ2 = 78.847, P = 0.001 | |||
Lymph node metastases | |||
Yes | (n = 23) | 35(76.1%) | 11(23.9%) |
No | (n = 127) | 248(97.6%) | 6(2.4%) |
χ2 = 33.838, P = 0.001 | |||
ER expression in breast cancer tissue | |||
Positive | (n = 40) | 70(87.5%) | 10(12.5%) |
Negative | (n = 92) | 179(97.3%) | 5(2.7%) |
Not studied | (n = 18) | 34(94.4%) | 2(5.6%) |
χ2 = 5.161, P = 0.023 |